Results 81 to 90 of about 5,533,665 (308)
City of Dublin Skin and Cancer Hospital Annual Report 2000
The City of Dublin Skin and Cancer Hospital located here in Hume Street has a proud tradition of service to the people of Dublin, a service which we, indeed, of the Eastern Regional Health Authority are anxious to see continued and expanded.
City of Dublin Skin and Cancer Hospital
core
Isocitrate dehydrogenase 1 (IDH1) mutations are highly recurrent in multiple human cancer types, including cholangiocarcinoma and glioma. IDH1 R132C is the most common IDH1 mutation in cholangiocarcinoma and likely arises from APOBEC3A‐ or APOBEC3B‐mediated deamination.
Kelly E. Butler +3 more
wiley +1 more source
Cancer Trends: HPV-associated cancers
Chronic infection with oncogenic (tumour-causing) strains of human papillomavirus (HPV) is now well-established as an important risk factor for anogenital (cervical, vaginal, vulvar, penile and anal/rectal) and head and neck (specifically oropharyngeal ...
National Cancer Registry Ireland (NCRI)
core
National Skin Cancer Prevention Plan 2023-2026
The National Cancer Strategy 2017-20261 aims to reduce the cancer burden in Ireland. Cancer prevention is a cornerstone of the National Cancer Strategy as it offers the most cost-effective, long-term approach for cancer control.
National Cancer Control Programme
core
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu +9 more
wiley +1 more source
Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba +5 more
wiley +1 more source
USP7 inhibits FOXO1 activity in chronic lymphocytic leukaemia cells enhancing cell survival
CLL cells rely on BCR‐mediated signalling for survival and proliferation in part through suppression of FOXO1. FOXO1 activity is regulated by a plethora of post‐translational modifications including phosphorylation and ubiquitination. We demonstrated that dual inhibition of BCR signalling and the deubiquitinase USP7 activates FOXO1, modulating its ...
Hassan N.B. Almuhanna +8 more
wiley +1 more source
Machine Learning and Its Application in Skin Cancer
Artificial intelligence (AI) has wide applications in healthcare, including dermatology. Machine learning (ML) is a subfield of AI involving statistical models and algorithms that can progressively learn from data to predict the characteristics of new ...
Clay J. Cockerell +6 more
core +1 more source
Cisplatin‐resistant cancer cells survive DNA‐damaging platinum‐based treatment yet remain sensitive to CuET‐induced proteotoxic stress. The distinct mechanism of action allows CuET to overcome and eliminate cisplatin‐resistant tumour cells, unless highly expressed metallothioneins (MTs) interfere with CuET, thereby highlighting MT levels as candidate ...
Stefanos Arampatzis +20 more
wiley +1 more source
BackgroundImmune checkpoint inhibitors (ICI) have revolutionized the treatment of advanced skin cancers. However, potentially severe and irreversible immune-related adverse events (irAEs) represent a major clinical challenge.
Nina Flatt +9 more
doaj +1 more source

